Having trouble viewing this email? View the online version.
ISSM logo

Latest News from the ISSM - May 15, 2015 Member Login
Sexual Medicine Seeks New Editor-in-Chief

The publication committee of the ISSM is pleased to announce openings for the Editor-in-Chief position for ISSM’s Open Access Journal Sexual Medicine. Please see the job description here

The editor will serve a 3-year initial term with a possibility of a 5 year extension based upon evaluation by the publication committee and the executive committee of the ISSM. Applications should be sent to the ISSM business office (secretariat@issm.info) by May 31, 2015.  Full application instructions are available here

Finalist candidates will be interviewed in Madrid at the ICSM 2015 International Consultation (Madrid, Spain, June 19-21, 2015) by the search committee, which shall consist of the Publication Committee, the current President and President-Elect of the ISSM. This committee includes the following members:

  • Tarek Anis, Egypt
  • Sidney Glina, Brazil
  • Luca Incrocci, the Netherlands
  • Wayne Hellstrom, U.S.A.
  • Shinichi Hisasue, Japan
  • Deepak Jumani, India
  • Ron Lewis, U.S.A.
  • Mario Maggi, Italy
  • Sharon Parish, U.S.A.
  • Raouf Seyam, Saudi Arabia
  • Ira Sharlip, U.S.A.
Study Compares ED Drugs' Efficacy and Side Effects

Phosphodiesterase type 5 (PDE5) inhibitors are a popular treatment for erectile dysfunction (ED), but efficacy and adverse events can vary. 

In a recent edition of European Urology, Swiss and Dutch researchers published their meta-analysis of 154 trials involving seven PDE5 inhibitors, in an effort to compare efficacy and side effect rates.

The team discovered that sildenafil 50 mg had the greatest efficacy, but it also had the highest rate of side effects of all the drugs studied. In contrast, tadalafil 10 mg had the lowest rate of side effects, but only “intermediate” efficacy.

Vardenafil 10 mg and avanafil 100 mg had lower efficacy with high rates of side effects. The efficacy of udenafil 100 mg was comparable to that of tadalafil 10 mg, but the drug had a higher rate of side effects.

The findings might help clinicians counsel patients on the pros and cons of different ED drugs. 

To learn more about this study, please click here.

Q & A: Intersex Conditions

When a child develops differently from a typical male or female, it's natural for parents and loved ones to have questions. In our latest Q & A item, we explain what intersex conditions are, provide some examples, and discuss treatment.

What does the term “intersex” mean?

Updated weekly, our website's Q & A feature covers a wide range of sexual health subjects of interest to your patients. Would you like to suggest a topic? Please feel free to send your ideas to us at QandA@issm.info.

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

ISSM | International Society for Sexual Medicine
P.O. Box 94 | 1520 AB Wormerveer | The Netherlands